Caseload continues to grow for the use of the broad category of products called "surgical securement", encompassing advanced products in surgical sealants, glues, hemostasis, and other wound closure and anti-adhesion products, according to a 2009 report by MedMarket Diligence, LLC.
"Worldwide, over 100 million surgical and traumatic wound types and applications are potential candidates for use of these products, and the breadth of these applications illustrate the great clinical utility of these products," says Patrick Driscoll of MedMarket Diligence. "These applications span cardiovascular, orthopedic and arthroscopic, digestive, urological, neurological, cosmetic, and general surgery, displacing many traditional wound closure products."
The market for surgical closure and securement has entered a phase in which major driving forces are the introduction of new procedures and techniques by the surgical profession, the development by the medical device industry of new wound closure devices and biomaterials, and the growing willingness of surgical specialists to use these devices in appropriate circumstances. There is now a continuum between simple closure using sutures and the use of specially designed devices and delivery systems with new bioresorbable securement materials either as supplements to conventional closure methodology or as stand-alone replacements.
Among all potential clinical applications, surgical securement products play critical roles in reducing mortality and complications for roughly 26 million surgical procedures and, in another 50 million surgical procedures, securement products provide distinct improvements in clinical outcomes. In another 40 million procedures, securement product reduce procedure time, provide cost savings or provide other benefits.
The MedMarket Diligence report #S175, "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2009-2013," is a market and technology assessment and forecast of products in wound closure. The report details the current and emerging products, technologies and markets involved in wound closure and sealing using sutures and staples, tapes, hemostats, fibrin and sealant products, medical adhesives and products to prevent post-surgical adhesions. The report provides a worldwide current and annual forecast to 2013 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade. The report provides specific forecasts and shares of the worldwide market by segment for the U.S., Europe (United Kingdom, German, France, Italy, BeNeLux), Latin America, Japan and Rest of World.
The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies.
The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.
For more details on this report, including description, table of contents, list of exhibits and ordering information, see http://www.mediligence.com/
The report may be ordered online (for immediate download) from http://www.mediligence.com/
About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes dedicated Reports on medical technology markets and offers the Medtech Startups Database on hundreds of newly founded medtech companies.
